このエントリーをはてなブックマークに追加
ID 56185
JaLCDOI
フルテキストURL
Thumnail 72_4_437.pdf 1.89 MB
著者
Koga, Yuhki Department of Pediatrics, Graduate School of Medical Sciences Kyushu University
Baba, Shingo Department of Clinical Radiology, Kyushu University Hospital
Fukano, Reiji Department of Pediatrics, Yamaguchi University Graduate School of Medicine
Nakamura, Katsumasa Department of Radiation Oncology, Hamamatsu University School of Medicine
Soejima, Toshinori Department of Radiation Oncology, Hyogo Cancer Center
Maeda, Naoko Department of Pediatrics, Nagoya Medical Center
Sunami, Shosuke Department of Pediatrics, Japanese Red Cross Narita Hospital
Ueyama, Junichi iDepartment of Pediatrics, Tottori University Hospital
Mitsui, Tetsuo Department of Pediatrics, Yamagata University Hospital,
Mori, Takeshi Department of Pediatrics, Kobe University
Osumi, Tomoo Children’s Cancer Center, National Center for Child Health and Development,
Sekimizu, Masahiro Department of Pediatrics, Nagoya Medical Center
Ohki, Kentaro Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development
Tanaka, Fumiko Department of Pediatrics, Saiseikai Yokohamashi Nanbu Hospital
Kamei, Michi Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences
Fujita, Naoto Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
Mori, Tetsuya Department of Pediatrics, St. Marianna University School of Medicine Hospital
Saito, Akiko M. Clinical Research Center, Nagoya Medical Center
Kada, Akiko Clinical Research Center, Nagoya Medical Center
Kobayashi, Ryoji Department of Pediatrics and Adolescence, Sapporo Hokuyu Hospital
抄録
This trial enrolls patients with untreated Hodgkin’s lymphoma aged<20 years at diagnosis and examines the effects of omitting radiation therapy if the FDG-positron emission tomography (PET) findings after two completed cycles of combination chemotherapy are negative. It thereby aims to determine whether patients who truly require radiation therapy can be identified by FDG-PET. If so, this modality could be used to omit radiation therapy for all other patients, decreasing the risk of serious long-term complications without affecting survival rates. The outcomes of patients for whom FDG-PET is used to assess early treatment response will also be determined.
キーワード
Hodgkin’s lymphoma
pediatric
fludeoxyglucose positron emission tomography
Amo Type
Clinical Study Protocol
発行日
2018-08
出版物タイトル
Acta Medica Okayama
72巻
4号
出版者
Okayama University Medical School
開始ページ
437
終了ページ
440
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
English
著作権者
CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID